$POLA
Polar Power, Inc. Stock $pola

$pola Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000149315224012355 Filed on April 01, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue	$4.660M	$3.605M	$15.29M
YoY Change	-16.59%	-43.37%	-4.75%
Cost Of Revenue	$2.828M	$5.032M	$14.60M
YoY Change	-31.23%	-15.57%	4.79%
Gross Profit	$1.832M	-$1.427M	$695.0K
YoY Change	24.2%	-451.48%	-67.29%
Gross Profit Margin	39.31%	-39.58%	4.54%
Selling, General & Admin	$1.177M	$1.488M	$5.463M
YoY Change	-18.66%	1.57%	-11.86%
% of Gross Profit	64.25%		786.04%
Research & Development	$195.0K	$239.0K	$1.222M
YoY Change	-42.31%	-24.13%	-16.3%
% of Gross Profit	10.64%		175.83%
Depreciation & Amortization	$55.00K	$77.00K	$387.0K
YoY Change	-50.0%	-35.83%	-23.67%
% of Gross Profit	3.0%		55.68%
Operating Expenses	$1.372M	$1.545M	$6.685M
YoY Change	-23.14%	-10.75%	-12.71%
Operating Profit	$460.0K	-$2.972M	-$5.990M
YoY Change	-248.39%	124.3%	8.26%
Interest Expense	$41.00K	-$184.0K	-$559.0K
YoY Change	-67.46%	868.42%	-1063.79%
% of Operating Profit	8.91%
Other Income/Expense, Net	$41.00K	$1.000K	$1.000K
YoY Change	-132.54%		-101.96%
Pretax Income	$501.0K	-$3.155M	-$6.548M
YoY Change	-214.91%	134.75%	17.26%
Income Tax
% Of Pretax Income
Net Earnings	$501.0K	-$3.155M	-$6.548M
YoY Change	-214.91%	134.75%	17.26%
Net Earnings / Revenue	10.75%	-87.52%	-42.82%
Basic Earnings Per Share	$0.03		-$0.49
Diluted Earnings Per Share	$0.03	-$0.22	-$0.49
COMMON SHARES
Basic Shares Outstanding	17.56M shares	12.96M shares	13.29M shares
Diluted Shares Outstanding	17.56M shares		13.29M shares

Balance Sheet

Concept	2024 Q2	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.119M	$549.0K	$549.0K
YoY Change	283.22%	160.19%	160.19%
Cash & Equivalents	$1.119M	$549.0K	$549.0K
Short-Term Investments
Other Short-Term Assets	$387.0K	$2.455M	$2.455M
YoY Change	-87.31%	-46.96%	-46.96%
Inventory	$15.78M	$16.52M	$16.52M
Prepaid Expenses	$387.0K	$455.0K
Receivables	$2.310M	$1.676M	$1.676M
Other Receivables	$0.00	$787.0K	$787.0K
Total Short-Term Assets	$19.59M	$21.99M	$21.99M
YoY Change	-23.28%	-5.7%	-5.7%
LONG-TERM ASSETS
Property, Plant & Equipment	$241.0K	$3.162M	$3.162M
YoY Change	-52.28%	487.73%	306.43%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$108.0K	$108.0K	$108.0K
YoY Change	16.13%	16.13%	16.13%
Total Long-Term Assets	$2.588M	$3.270M	$3.270M
YoY Change	-6.77%	275.43%	275.43%
TOTAL ASSETS
Total Short-Term Assets	$19.59M	$21.99M	$21.99M
Total Long-Term Assets	$2.588M	$3.270M	$3.270M
Total Assets	$22.18M	$25.26M	$25.26M
YoY Change	-21.66%	4.43%	4.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$597.0K	$1.762M	$1.762M
YoY Change	-58.22%	666.09%	666.09%
Accrued Expenses	$2.416M	$2.275M	$2.275M
YoY Change	23.33%	51.77%	51.77%
Deferred Revenue
YoY Change
Short-Term Debt	$4.683M	$4.238M	$4.238M
YoY Change	-4.95%	124.95%	124.95%
Long-Term Debt Due	$274.0K	$321.0K	$321.0K
YoY Change	-7.12%	52.13%	52.13%
Total Short-Term Liabilities	$9.439M	$10.21M	$10.21M
YoY Change	-6.96%	71.66%	71.66%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Other Long-Term Liabilities	$1.193M	$1.856M	$1.856M
YoY Change	-21.87%
Total Long-Term Liabilities	$1.193M	$1.856M	$1.856M
YoY Change	-22.28%	3156.14%	3156.14%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.439M	$10.21M	$10.21M
Total Long-Term Liabilities	$1.193M	$1.856M	$1.856M
Total Liabilities	$10.63M	$12.07M	$12.07M
YoY Change	-8.97%	100.93%	100.93%
SHAREHOLDERS EQUITY
Retained Earnings	-$27.30M	-$25.66M
YoY Change	32.14%	34.26%
Common Stock	$2.000K	$2.000K
YoY Change	100.0%	100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$11.55M	$13.19M	$13.19M
YoY Change
Total Liabilities & Shareholders Equity	$22.18M	$25.26M	$25.26M
YoY Change	-21.66%	4.43%	4.43%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$501.0K	-$3.155M	-$6.548M
YoY Change	-214.91%	134.75%	17.26%
Depreciation, Depletion And Amortization	$55.00K	$77.00K	$387.0K
YoY Change	-50.0%	-35.83%	-23.67%
Cash From Operating Activities	$1.179M	-$350.0K	-$3.430M
YoY Change	-171.54%	-82.28%	-47.29%
INVESTING ACTIVITIES
Capital Expenditures	$18.00K	$4.000K	$194.0K
YoY Change	-90.72%		676.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$18.00K	-$4.000K	-$194.0K
YoY Change	-90.72%		676.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$1.556M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-254.0K	602.0K	3.962M
YoY Change	-112.61%	-66.98%	141.29%
NET CHANGE
Cash From Operating Activities	1.179M	-350.0K	-3.430M
Cash From Investing Activities	-18.00K	-4.000K	-194.0K
Cash From Financing Activities	-254.0K	602.0K	3.962M
Net Change In Cash	907.0K	248.0K	338.0K
YoY Change	424.28%	-263.16%	-106.91%
FREE CASH FLOW
Cash From Operating Activities	$1.179M	-$350.0K	-$3.430M
Capital Expenditures	$18.00K	$4.000K	$194.0K
Free Cash Flow	$1.161M	-$354.0K	-$3.624M
YoY Change	-163.03%	-82.08%	-44.52%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown		usd
CY2023	POLA	Stock Issued During Period Values Common Stock Issued Upon Exercise Of Warrants StockIssuedDuringPeriodValuesCommonStockIssuedUponExerciseOfWarrants		usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown		usd
CY2022	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2022	POLA	Initial Recognition Of Operating Lease Rightofuse Assets And Operating Lease Liabilities InitialRecognitionOfOperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilities		usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
CY2022	POLA	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2022	POLA	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
CY2023	POLA	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber		shares
CY2023Q4	POLA	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
CY2023Q4	POLA	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber		shares
CY2023Q4	POLA	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2023Q4	POLA	Deferred Tax Liabilities Depreciation DeferredTaxLiabilitiesDepreciation		usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	9560132	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	17561612	shares
CY2023	dei	Auditor Firm AuditorFirmId	572
CY2023	dei	Auditor Name AuditorName	Weinberg & Company, P.A
CY2023	dei	Auditor Location AuditorLocation	Los Angeles, California
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	549000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	211000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1676000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2230000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	16522000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	15460000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	455000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2629000	usd
CY2023Q4	POLA	Employee Retention Credit Receivable EmployeeRetentionCreditReceivable	2000000	usd
CY2022Q4	POLA	Employee Retention Credit Receivable EmployeeRetentionCreditReceivable	2000000	usd
CY2023Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	787000	usd
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	787000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	21989000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	23317000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2818000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	240000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	344000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	538000	usd
CY2023Q4	us-gaap	Deposit Assets DepositAssets	108000	usd
CY2022Q4	us-gaap	Deposit Assets DepositAssets	93000	usd
CY2023Q4	us-gaap	Assets Assets	25259000	usd
CY2022Q4	us-gaap	Assets Assets	24188000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1762000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	230000	usd
CY2023Q4	us-gaap	Deposits Deposits	1618000	usd
CY2022Q4	us-gaap	Deposits Deposits	2126000	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1151000	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1231000	usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	4238000	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1884000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1124000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	268000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10214000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5950000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1856000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	12070000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	6007000	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17579089	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17561612	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12967027	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12949550	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	2000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	38886000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	37331000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25659000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19111000	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	17477	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	17477	shares
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	40000	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	40000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	13189000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	18181000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25259000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24188000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15293000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16056000	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	450000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	14598000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	13931000	usd
CY2023	us-gaap	Gross Profit GrossProfit	695000	usd
CY2022	us-gaap	Gross Profit GrossProfit	2125000	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1172000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1471000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1222000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1460000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4291000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4727000	usd
CY2023	us-gaap	Interest Expense InterestExpense	559000	usd
CY2022	us-gaap	Interest Expense InterestExpense	58000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	7000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-558000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-51000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6548000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5584000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.49
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.49
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.43
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.43
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13291575	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13291575	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12878350	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12878350	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	23250000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	515000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5584000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	18181000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	18181000	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1556000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6548000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	13189000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	13189000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6548000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5584000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	387000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	507000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	515000	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	450000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-554000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2013000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1512000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6443000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-2174000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-1377000	usd
CY2023	POLA	Increase Decrease In Amortization Right Of Use Asset IncreaseDecreaseInAmortizationRightOfUseAsset	-1000000	usd
CY2022	POLA	Increase Decrease In Amortization Right Of Use Asset IncreaseDecreaseInAmortizationRightOfUseAsset	-674000	usd
CY2023	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	15000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1532000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-98000	usd
CY2023	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-508000	usd
CY2022	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	1229000	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-80000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	25000	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-864000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-722000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3430000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6507000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	194000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	25000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-194000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-25000	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1556000	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	257000	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	205000	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	242000	usd
CY2023	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	2354000	usd
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1884000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3962000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1642000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	338000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4890000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	211000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5101000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	549000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	211000	usd
CY2023	POLA	Initial Recognition Of Operating Lease Rightofuse Assets And Operating Lease Liabilities InitialRecognitionOfOperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilities	3578000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6548000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3430000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	549000	usd
CY2023Q4	POLA	Line Of Credit Borrowing Capacity LineOfCreditBorrowingCapacity	376000	usd
CY2023Q4	POLA	Working Capital WorkingCapital	11775000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_848_eus-gaap--UseOfEstimates_zShtEcMsCtMf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zzCVBoJpWp52">Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Material estimates relate to the assumptions made in determining estimates for credit loss reserves for accounts receivable, assumptions used in valuing inventories at net realizable value, impairment testing of recorded long-term assets, the realizability of deferred tax assets and the related valuation allowance, accruals for warranty reserves, accruals for potential liabilities, assumptions made in valuing stock instruments issued for services, and assumptions used in the determination of the Company’s liquidity. Actual results may differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15293000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16056000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15293000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16056000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15293000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16056000	usd
CY2023Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	600000	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	600000	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	600000	usd
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	600000	usd
CY2023	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	469000	usd
CY2022	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	508000	usd
CY2023	POLA	Standard Product Warranty Accrual Provision StandardProductWarrantyAccrualProvision	469000	usd
CY2022	POLA	Standard Product Warranty Accrual Provision StandardProductWarrantyAccrualProvision	508000	usd
CY2023Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	600000	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	600000	usd
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	450000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	14313000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	12277000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2209000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3183000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	16522000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	15460000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1222000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1460000	usd
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	140000	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	164122	shares
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_847_eus-gaap--ConcentrationRiskCreditRisk_zDA5LjMK9De7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zWRkH3uqOKL1">Concentrations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenues</i>. For the year ended December 31, 2023, <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__srt--MajorCustomersAxis__custom--LargestCustomerOneMember__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z2rfRRlfjYc9" title="Concentration risk">50</span>% and <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__srt--MajorCustomersAxis__custom--LargestCustomerTwoMember__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zmovsmo671I4" title="Concentration risk">18</span>%, respectively, of our revenue was generated from the Company’s two largest customers, one being a Tier-1 telecommunications customer in the U.S. and one being a telecommunications customer outside the U.S In 2022, <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--LargestCustomerOneMember__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--RangeAxis__srt--MaximumMember_zG3nfADnm8De" title="Concentration risk">66</span>% and <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--LargestCustomerOneMember__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--RangeAxis__srt--MinimumMember_zaGSebpb1c6k" title="Concentration risk">23</span>%, respectively, of our revenue was generated from the Company’s two largest customers, one being a Tier-1 telecommunications customer in the U.S. and one being a telecommunications customer outside the U.S. In 2023 and 2022, sales to telecommunications customers accounted for <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_zzUJbNvcWl29" title="Concentration risk">95</span>% and <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_zMoowimBka55" title="Concentration risk">96</span>% of total revenue, respectively. In 2023 and 2022, sales to international customers accounted for <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__srt--ProductOrServiceAxis__custom--SalesToInternationalCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_zYmKmwuddb47" title="Concentration risk">21</span>% and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--ProductOrServiceAxis__custom--SalesToInternationalCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_zmULv48eePv6" title="Concentration risk">25</span>% of total revenue, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts receivable</i>. At December 31, 2023, the Company’s two largest receivable accounts represented <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__srt--MajorCustomersAxis__custom--LargestReceivableAccountsOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zwBkliFtwdT2" title="Concentration risk">69</span>% and <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__srt--MajorCustomersAxis__custom--LargestReceivableAccountsTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zzBSmaUJtPfe" title="Concentration risk">16</span>% of the Company’s total accounts receivable. At December 31, 2022, the Company’s largest receivable account represented <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--LargestReceivableAccountsMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zRVUDestSDs3" title="Concentration risk">90</span>% of the Company’s total accounts receivable. There was no other customer that accounted for more than 10% of the Company’s accounts receivable as of the years ended December 31, 2023 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts payable</i>. On December 31, 2023, the three largest accounts payable accounts to the Company’s vendors represented <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__srt--MajorCustomersAxis__custom--LargestVendorsOnesMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zu7WCq5BDvV" title="Concentration risk">30</span>%, <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__srt--MajorCustomersAxis__custom--LargestCustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z4lqyTvf04Bc" title="Concentration risk">10</span>%, and <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__srt--MajorCustomersAxis__custom--LargestCustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zPjXUkgWcHgl" title="Concentration risk">5</span>%, respectively. On December 31, 2022, the three largest accounts payable accounts to the Company’s vendors represented <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--LargestVendorsOnesMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_z2lCB5uI9zN" title="Concentration risk">51</span>%, <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--LargestCustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zRJRvb9DlgC6" title="Concentration risk">3</span>%, and <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--LargestCustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zNzozypBUGW5" title="Concentration risk">3</span>%, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4494000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4300000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4150000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3762000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	344000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	538000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	387000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	507000	usd
CY2023	us-gaap	Depreciation Depreciation	374000	usd
CY2022	us-gaap	Depreciation Depreciation	489000	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	64000	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	268000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	57000	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	268000	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	205000	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	64000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	64000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	64000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	89000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	111000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	125000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	3896000	usd
CY2023	POLA	Initial Recognition Of Operating Lease Rightofuse Assets And Operating Lease Liabilities InitialRecognitionOfOperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilities	3578000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	1123000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	699000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	1123000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	699000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y4M24D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y4M24D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0513	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0375	pure
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	140000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	140000	shares
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2818000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	240000	usd
CY2023Q4	POLA	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	760000	usd
CY2022Q4	POLA	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	2577000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2818000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	240000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1124000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	268000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1856000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2980000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	268000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1250000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1446000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	496000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3192000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	212000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2980000	usd
CY2023	us-gaap	Payments For Rent PaymentsForRent	1423000	usd
CY2022	us-gaap	Payments For Rent PaymentsForRent	975000	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	17477	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	17477	shares
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	40000	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	40000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	140000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.22
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	140000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.22
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	140000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.22
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	24122	shares
CY2021Q4	POLA	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	3.13
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	24122	shares
CY2022Q4	POLA	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	3.13
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	24122	shares
CY2023	POLA	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice	0.40
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	24122	shares
CY2023Q4	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	12062	shares
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.07	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.07	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.28	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.28	pure
CY2023Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	977000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1462000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	256000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	254000	usd
CY2023Q4	POLA	Deferred Tax Assets Operating Lease Liability DeferredTaxAssetsOperatingLeaseLiability	834000	usd
CY2022Q4	POLA	Deferred Tax Assets Operating Lease Liability DeferredTaxAssetsOperatingLeaseLiability	75000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5065000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3262000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	7132000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	5053000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6737000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4863000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	395000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	190000	usd
CY2023Q4	POLA	Deferred Tax Liability Operating Lease Rightofuse Asset Net DeferredTaxLiabilityOperatingLeaseRightofuseAssetNet	395000	usd
CY2022Q4	POLA	Deferred Tax Liability Operating Lease Rightofuse Asset Net DeferredTaxLiabilityOperatingLeaseRightofuseAssetNet	67000	usd
CY2022Q4	POLA	Deferred Tax Liabilities Depreciation DeferredTaxLiabilitiesDepreciation	123000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	395000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	190000	usd
CY2023	us-gaap	Tax Credit Carryforward Description TaxCreditCarryforwardDescription	the TCJA limits NOL absorption to 80% of taxable income.
CY2023Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	787000	usd
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	787000	usd
CY2023Q4	POLA	Offset Of Taxable Income Percentage OffsetOfTaxableIncomePercentage	0.80	pure
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2021	POLA	Employee Retention Credits Wages Percentage EmployeeRetentionCreditsWagesPercentage	0.70	pure
CY2021	POLA	Employee Retention Credits Per Shares EmployeeRetentionCreditsPerShares	7
CY2021Q4	POLA	Expenses Of Employee Retention Credit ExpensesOfEmployeeRetentionCredit	2000000	usd
CY2021	POLA	Employee Retention Credits Cost Of Sales EmployeeRetentionCreditsCostOfSales	1300000	usd
CY2021	POLA	Employee Retention Credits Operating Expenses EmployeeRetentionCreditsOperatingExpenses	700000	usd
CY2023Q4	POLA	Employee Retention Credit Receivable EmployeeRetentionCreditReceivable	2000000	usd
CY2022Q4	POLA	Employee Retention Credit Receivable EmployeeRetentionCreditReceivable	2000000	usd

Files In Submission

Name	View Source	Status
0001493152-24-012355-index-headers.html	Edgar Link	pending
0001493152-24-012355-index.html	Edgar Link	pending
0001493152-24-012355.txt	Edgar Link	pending
0001493152-24-012355-xbrl.zip	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex4-1.htm	Edgar Link	pending
ex97-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pola-20231231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
pola-20231231_cal.xml	Edgar Link	unprocessable
pola-20231231_def.xml	Edgar Link	unprocessable
pola-20231231_lab.xml	Edgar Link	unprocessable
pola-20231231_pre.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$POLA
Polar Power, Inc. Stock $pola

2024 Q2 Form 10-K Financial Statement

#000149315224012355 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$POLA Polar Power, Inc. Stock $pola

2024 Q2 Form 10-K Financial Statement

#000149315224012355 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$POLA
Polar Power, Inc. Stock $pola